subscribe
 

Lab automation goes live in Ipswich

Sophisticated laboratory automation provides superior pathology services in Ipswich



Nip in the bud for drug substitute

Drug policy expert argues the Italian government should reconsider the decision to substitute AMD drug for the safety of patients



Clot-free blood gas testing

Particularly important in the monitoring of critically ill patients where rapid, reliable results and minimal delays are extremely important



Roche’s Avastin approved in Japan

First approval of Avastin for the treatment of newly diagnosed glioblastoma in combination with radiotherapy and temozolomide chemotherapy



Roche to present important new data reflecting broad cancer pipeline at ASCO

Roche has announced that important new data from clinical trials of several investigational and approved cancer medicines will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 31 to June 4, 2013, in Chicago.



Benelux and Scandinavian glucose monitoring devices markets to hit $783m by 2020

Roche and LifeScan among strongest players in market in Benelux, says GBI Research



Roche launches new ProGRP test for more precise diagnosis in lung cancer

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu.



Roche halts investigation of aleglitazar

Roche has announced that following the results of a regular safety review of the aleglitazar AleCardio phase III trial, the independent Data and Safety Monitoring Board (DSMB) has recommended to halt the trial due to safety signals and lack of efficacy.



Roche's RoACTEMRA approved in EU to treat children with rare form of arthritis

Roche has announced that the European Medicines Agency has approved RoACTEMRA to treat children with polyarticular juvenile idiopathic arthritis (PJIA), a rare, chronic and debilitating form of childhood arthritis.



Roche launches new test for diagnosis and monitoring of thyroid cancer

Roche has announced the launch of Elecsys Calcitonin, a new laboratory test for the diagnosis and lifelong monitoring of medullary thyroid cancer patients after thyroid surgery.



Roche Enzymatic Creatinine Assay

The Roche Creatinine Plus enzymatic creatinine assay, for use with cobas or MODULAR Analytics analysers, offers a specific and accurate alternative to the less specific methods.



Roche launches new process for accessing clinical trial data

Roche has announced that it is expanding access to its clinical trial data for third party researchers.



Roche and IMI promote use of stem cell technology to enhance drug development

Roche and the Innovative Medicines Initiative have announced the launch of StemBANCC, a new academic–industry partnership that unites ten pharmaceutical companies and 23 academic institutions.



Roche medicine Avastin receives EU approval

Roche has announced that the European Commission has approved Avastin (bevacizumab) in combination with standard chemotherapy as a treatment for women with first recurrence of platinum-sensitive ovarian cancer.



Roche / Avastin study

Roche study showed that adding Avastin to radiation and chemotherapy significantly extended the time people with an aggressive form of brain cancer lived without their disease worsening.



Roche launches 454 sequencing assays

Roche has announced the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes using the company’s 454 GS Junior and GS FLX Systems



Roche reports positive study of RoACTEMRA given by subcutaneous injection

Roche has announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy of the subcutaneous (SC) formulation of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) 162mg weekly compared to 8 mg/kg RoACTEMRA intravenous (IV) formulation every 4 weeks.



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe